Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Navarro

Showing results (481-490 of 692) with videos related to

Pageof 70
Sort By:
International Journal of Molecular Sciences|August 28, 2025
Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor AgonistsVicente Llinares-Arvelo, Carlos E Martínez-Alberto, Ainhoa González-Luis, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1997
Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patientsJ F Navarro, M L Macía, C Mora-Fernández, et al.
Anales Otorrinolaringologicos Ibero-Americanos|February 28, 2002
[Subcutaneous cervico-thoracic emphysema and pneumo-mediastinum following a tracheostomy]J J Rivarés Esteban, P J Gil Paraíso, F Navarro Díaz, et al.
European Journal of Endocrinology|October 30, 2025
Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatmentAinhoa González-Luis, Vicente Llinares-Arvelo, Carlos E Martínez-Alberto, et al.
Clinical Kidney Journal|June 15, 2019
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?Beatriz Fernandez-Fernandez, Raul Fernandez-Prado, Jose Luis Górriz, et al.
Transplantation|July 29, 2016
Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant RecipientsJavier Donate-Correa, Fernando Henríquez-Palop, Ernesto Martín-Núñez, et al.
Current Drug Targets|April 22, 2014
Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney diseaseJavier Donate-Correa, Virginia Domínguez-Pimentel, Mercedes Muros-de-Fuentes, et al.
Anales Otorrinolaringologicos Ibero-Americanos|June 11, 2002
[Post-traumatic carotid cavernous fistula as a cause of objective tinnitus]J J Rivarés Esteban, P J Gil Paraíso, J Marín García, et al.
Blood|October 9, 1999
Signaling through CD43 induces natural killer cell activation, chemokine release, and PYK-2 activationM Nieto, J L Rodríguez-Fernández, F Navarro, et al.
Cytokine & Growth Factor Reviews|December 27, 2015
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetesJavier Donate-Correa, Ernesto Martín-Núñez, Nayra Pérez Delgado, et al.
Pageof 70

Showing results (481-490 of 692) with videos related to

Sort By:
Pageof 70
International Journal of Molecular Sciences|August 28, 2025
Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor AgonistsVicente Llinares-Arvelo, Carlos E Martínez-Alberto, Ainhoa González-Luis, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1997
Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patientsJ F Navarro, M L Macía, C Mora-Fernández, et al.
Anales Otorrinolaringologicos Ibero-Americanos|February 28, 2002
[Subcutaneous cervico-thoracic emphysema and pneumo-mediastinum following a tracheostomy]J J Rivarés Esteban, P J Gil Paraíso, F Navarro Díaz, et al.
European Journal of Endocrinology|October 30, 2025
Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatmentAinhoa González-Luis, Vicente Llinares-Arvelo, Carlos E Martínez-Alberto, et al.
Clinical Kidney Journal|June 15, 2019
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?Beatriz Fernandez-Fernandez, Raul Fernandez-Prado, Jose Luis Górriz, et al.
Transplantation|July 29, 2016
Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant RecipientsJavier Donate-Correa, Fernando Henríquez-Palop, Ernesto Martín-Núñez, et al.
Current Drug Targets|April 22, 2014
Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney diseaseJavier Donate-Correa, Virginia Domínguez-Pimentel, Mercedes Muros-de-Fuentes, et al.
Anales Otorrinolaringologicos Ibero-Americanos|June 11, 2002
[Post-traumatic carotid cavernous fistula as a cause of objective tinnitus]J J Rivarés Esteban, P J Gil Paraíso, J Marín García, et al.
Blood|October 9, 1999
Signaling through CD43 induces natural killer cell activation, chemokine release, and PYK-2 activationM Nieto, J L Rodríguez-Fernández, F Navarro, et al.
Cytokine & Growth Factor Reviews|December 27, 2015
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetesJavier Donate-Correa, Ernesto Martín-Núñez, Nayra Pérez Delgado, et al.
Pageof 70